Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication indicated for attention deficit hyperactivity disorder in children and adults . In Canada, its access is overseen by Health Canada. This https://sandozlisdexamfetaminepr571522.octoberblog.com/61734901/lisdexamfetamine-in-canada-a-detailed-guide